m2m teams with invivoContrast

AuntMinnie.com staff writers
Jun 27, 2010

m2m Imaging of Cleveland and invivoContrast of Berlin are partnering to bring invivoContrast's preclinical contrast agents to North America through m2m's sales and marketing relationships.

m2m Imaging is a global supplier of coil systems and accessories for preclinical research in MR and multimodality imaging to academic sites and national labs, as well as for drug discovery and safety markets for pharmaceutical R&D.

invivoContrast specializes in the commercialization of specialized contrast agents for preclinical research.

Related Reading

Supertron acquires Spin Systems, changes name to m2m Imaging, November 9, 2006

Copyright © 2010 AuntMinnie.com

Latest in Clinical News
Paul McCoubrie, MBBS.
The challenges of dysrhythmic radiologists
January 3, 2025
Mri Breast Cancer
Women with BRCA1/2 germline mutations are often denied breast MRI
January 3, 2025
Women Cancer Patient
Starting breast cancer screening at 40 is more cost-effective
January 3, 2025
Prostate Cancer
PSMA-PET/CT bests conventional imaging for prostate cancer diagnosis
January 3, 2025
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2010 06 25 15 43 12 346 Michopoulu thumb 06 2010
MRI
CAD eases MRI-based herniated disk diagnosis
2010 06 25 15 08 05 428 Avila thumb 2010 06
CT
CT method measures airway calcium to diagnose lung cancer
2010 06 28 15 12 37 614 Pacs Maturity New 750
Clinical News
Dutch study quantifies factors that make PACS work
More in Clinical News
The challenges of dysrhythmic radiologists
By Paul McCoubrie, MBBS
In a new column, Paul McCoubrie, MBBS, discusses the characteristics of "dysrhythmic" radiologists.
January 3, 2025
Paul McCoubrie, MBBS.
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Starting breast cancer screening at 40 is more cost-effective
By Amerigo Allegretto
Starting breast cancer screening at age 40 is tied to improved patient outcomes and reduced healthcare spending on treatment.
January 3, 2025
Women Cancer Patient
PSMA-PET/CT bests conventional imaging for prostate cancer diagnosis
By Kate Madden Yee
PSMA-PET/CT bests conventional imaging when it comes to identifying high-risk, nonmetastatic, hormone-sensitive prostate cancer, researchers say.
January 3, 2025
Prostate Cancer
Deep learning plus DCE-MRI predicts breast cancer treatment response
By Amerigo Allegretto
A deep-learning system based on DCE-MRI can predict pathological complete response in breast cancer patients.
January 2, 2025
Mri Breast Cancer
Are patients satisfied with interventional radiology experiences?
By Will Morton
Interventional radiologists who excel in communication, positive outcomes, and cultural competence receive high patient ratings.
January 2, 2025
Interventional Radiology
2009 USPSTF guidelines not linked to higher breast cancer incidence
By Amerigo Allegretto
Breast cancer screening guidelines issued in 2009 have not led to increased or decreased breast cancer incidence.
December 27, 2024
Breast Cancer3 400 (2)
New MRI method shows treatment effects in lung transplant patients
By Kate Madden Yee
A new method of MRI lung scanning shows the effects of treatment for compromised lung function in transplant patients, U.K. researchers have reported.
December 24, 2024
Lung Function Mri Showing Measurements In Lung Transplant Recipients Thumbnail
Deep-learning model plus CT predicts liver decompensation in PSC patients
By Amerigo Allegretto
A deep-learning model applied to CT imaging can predict liver decompensation in patients with primary sclerosing cholangitis (PSC).
December 23, 2024
Researchers have developed a CT-based deep-learning model for predicting liver decompensation in PSC patients. Pictured is the team's diagram of the pipeline it developed for distinguishing between decompensation and no decompensation is presented in various planes. Image courtesy of Yashbir Singh, PhD.
AI improves diagnosis of acute PE, and thus patient care
By Kate Madden Yee
Using an AI-based prioritization algorithm with CTPA to diagnose acute pulmonary embolism could enhance patient care by getting imaging results to clinicians more quickly.
December 23, 2024
Am 2022 06 09 21 09 4701 Pulmonary Embolism Illustration V2 400
40% of women in their 40s forgo biennial breast cancer screening
By Amerigo Allegretto
About two in every five women in their 40s do not undergo biennial breast cancer screening per USPSTF recommendations.
December 20, 2024
Mammogram Patient
Kidneys appear to tolerate Lu-177 treatments
By Will Morton
Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.
December 19, 2024
Kidneys
Page 1 of 3620
Next Page